Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Artal Participations is a private investment holding company based in Luxembourg and a core entity of the Artal Group. The firm is managed by its exclusive investment advisor, The Invus Group, and is characterized by a long-term "evergreen" investment philosophy that provides patient capital to its portfolio companies. Artal is highly prominent in the healthcare and wellness sectors, notably for its long-standing controlling interest in WW International (WeightWatchers). In the biotechnology industry, Artal has been the primary financial backer and majority shareholder of Lexicon Pharmaceuticals for several decades, supporting the development of therapies for heart failure and diabetes. The company's investment strategy focuses on transformative businesses in consumer health, life sciences, and specialized services across the United States and Europe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Artal Participations.